Skip to main content
SpringerLink
Log in

Depression

  • Chapter
Medikamentös induzierte neurologische und psychiatrische Störungen

  • 782 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 19.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 37.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adam D, Löscher T, Michel D, Mertens TH (1999) Antiinfektive Chemotherapie. In: Müller-Oerlinghausen B, Lasek R, Düppenbecker H, Munter KH (Hrsg) Handbuch der unerwünschten Arzneimittelwirkungen. Urban & Fischer, München, S 38–109

    Google Scholar 

  • Ambrose A, Salib B (1999) Amiodarone-induced depression. Br J Psychiat 174: 366–367

    CAS  Google Scholar 

  • Bandelow B, Muller P, Gaebel W (1990) Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin Düsseldorf Göttingen Munich. Eur Arch Psy Clin N 240: 113–120

    CAS  Google Scholar 

  • Bandelow B, Müller P, Frick U (1992) Depressive syndromes in schizophrenic patients under neuroleptic therapy. ANI Study Group Berlin Düsseldorf Göttingen Munich. Eur Arch Psy Clin N 241:291–295

    CAS  Google Scholar 

  • Bandelow B, Grohmann R, Rüther E (2000) Unerwünschte Begleitwirkungen der Neuroleptika und ihre Behandlung. In: Möller HJ (Hrsg) Therapie psychiatrischer Erkrankungen. Thieme, Stuttgart, S 217–235

    Google Scholar 

  • Barabas G, Matthews WS (1988) Barbiturate anticonvulsants as a cause of severe depression. Pediatrics 82: 284–285

    PubMed  CAS  Google Scholar 

  • Behrend K, Brack J, Tretter F (2003) Opiatentzugsbehandlung. In: Krausz M, Haasen C, Naber D (Hrsg) Pharmakotherapie der Sucht. Karger, Basel, S 40–70

    Google Scholar 

  • Benson D, Peterson LG, Bartay J (1983) Neuropsychiatric manifestations of antihypertensive medications. Psychiatr Med 1: 205–214

    PubMed  CAS  Google Scholar 

  • Berger M, Calker D van (2004) Affektive Störungen. In: Berger M (Hrsg) Psychische Erkrankungen. Klinik und Therapie. Urban & Fischer, München, S 542–636

    Google Scholar 

  • Broich K (1999) Substanzinduzierte unipolare und bipolare Störungen. In: Mameros A (Hrsg) Handbuch der unipolaren und bipolaren Erkrankungen. Thieme, Stuttgart, S 544–551

    Google Scholar 

  • Brown ES, Suppes T (1998) Mood symptoms during corticosteroidtherapy. A review. Harvrad Rev Psychiat 5: 239–246

    CAS  Google Scholar 

  • Bunney WE, Davis JM (1965) Norepinephrine in depressive reactions. A review. Arch Gen Psychiat 13:483–494

    PubMed  CAS  Google Scholar 

  • Calker D van, Walden J (1994) Valproat in der Psychiatrie. W. Zuckschwerdt, München

    Google Scholar 

  • Chadwick D (1999) Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group. Lancet 345: 476–479

    Google Scholar 

  • Chengappa KNR, Gershon S, Levine J (2001) The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. Bipolar Disord 3: 215–232

    PubMed  CAS  Google Scholar 

  • Cohen GD (1990) Prevalence of psychiatric problems in older adults. Psychiatr Ann 20: 433–438

    Google Scholar 

  • Dassylva B (1993) Verapamil may cause depression. Can J Psychiat 38: 299–300

    CAS  Google Scholar 

  • Derogatis LR, Morrow GR, Feting J (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249: 751–766

    Article  PubMed  CAS  Google Scholar 

  • Diaz-Olavarietta C, Cummings JL, Velazquez J (1999) Neuropsychiatric manifestations of multiple sclerosis. J Neuropsych Clin N 11: 51–57

    Google Scholar 

  • Dimsdale JE, Newton RP, Joist T (1989) Neuropsychological side effects of beta blockers. Arch Int Med 149: 514–525

    CAS  Google Scholar 

  • Duits N, Bos FM (1993) Depressive symptoms and cholesterol lowering drugs. Lancet 341: 114

    Article  PubMed  CAS  Google Scholar 

  • Engelberg H (1992) Low cholesterol and suicide. Lancet 339: 727

    Article  PubMed  CAS  Google Scholar 

  • Frank JW, Reed DM, Grove JS (1992) Will lowering population levels of serum cholesterol affect total mortality? J Clin Epidemiol 45: 333–346

    Article  PubMed  CAS  Google Scholar 

  • Fröscher W, Rösche J (2001) Levetiracetam. Arzneimitteltherapie 19: 275–281

    Google Scholar 

  • Furin JJ, Mitnick CD, Shin SS et al. (2001) Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 5(7): 648–655

    PubMed  CAS  Google Scholar 

  • Futrell N, Schultz LR, Millikan C (1992) Central nervous system disease in patients with systemic lupus erythematosus. Neurology 42: 1649–1657

    PubMed  CAS  Google Scholar 

  • Gerstman BB, Jolson HM, Bauer M (1996) The incidence of depression in new users of beta-blockers and selective antihypertensive. J Clin Epidemiol 49: 809–815

    Article  PubMed  CAS  Google Scholar 

  • Goodwin F, Bunney WE (1971) Depression following reserpine: a reevaluation. Semin Psychiatry 3: 435–448

    PubMed  CAS  Google Scholar 

  • Gool AR van, Kruit WHJ, Engels FK, Stoter G, Bannink M, Eggermont AMM (2003) Neuropsychiatric side effects of interferon-alfa therapy. Pharm World Sci 25(1): 11–20

    PubMed  Google Scholar 

  • Gunduz H, Georges JL, Fleishman S (1999) Quinalapril and depression. Am J Psychiatry 156: 1114–1115

    PubMed  CAS  Google Scholar 

  • Hoff P (2003) Depressive Syndrome und Alkohol. In: Hegerl U, Hoff P (Hrsg) Depressions-behandlung unter komplizierenden Bedingungen. Komorbidität-Multimedikation-Geriatrische Patienten. Uni-Med, Bremen, S 70–74

    Google Scholar 

  • Holdiness M (1987) Neurobiological manifestations and toxicities of the antituberculosis drugs: a review. Med Toxicol 2: 33–51

    PubMed  CAS  Google Scholar 

  • IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis, I: clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 655–661

    Google Scholar 

  • Jacobs LD, Cookfair DL, Rudnick RA (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRF). Ann Neurol 39: 285–294

    Article  PubMed  CAS  Google Scholar 

  • Jarkova NB, Martenyi F, Masanauskaite D (2002) Mood effect of raloxifene in postmenopausal women. Maturitas 42(1): 71–75

    Article  PubMed  CAS  Google Scholar 

  • Kanner AM, Nieto JC (1999) Depressive disorders in epilepsy. Neurology 53(5 Suppl 2): 26–32

    Google Scholar 

  • Kanowsky S (1994) Age-dependent epidemiology of depression. Gerontology 40(Suppl 1): 1–4

    Google Scholar 

  • Kasper S, Jung B (1995) Psychiatrisch relevante Nebenwirkungen der nichtpsychopharmakologischen Pharmakotherapie. Nervenarzt 66: 649–661

    PubMed  CAS  Google Scholar 

  • Kassler-Taub B, Woodward T, Markowitz TS (1993) Depressive symptoms and pravastatin. Lancet 341: 371–372

    PubMed  CAS  Google Scholar 

  • Kaufmann DM (2001) Clinical Neurology for Psychiatrists. WB Saunders, Philadelphia, pp 369–392

    Google Scholar 

  • Keller S, Frishman WH, Nurenberg J (1997) Neuropsychiatric effects of cardiovascular medications. In: Frishman WH, Sonnenblick EH (eds) Cardiovascular Pharmacotherapeutics. McGraw-Hill, New York, pp 1053–1071

    Google Scholar 

  • Keller S, Frishman WH (2003) Neuropsychiatric effects of cardiovascular drug therapy. Cardiology in Review 11(2): 73–93

    PubMed  Google Scholar 

  • Kendler K, Martin N, Heath A, Handelsman D, Eaves L (1988) A twin study of the psychiatric side effects of oral contraceptives. J Nerv Ment Dis 176: 153–160

    PubMed  CAS  Google Scholar 

  • Keshavan MS (1997) latrogenic depression. In: Robertson MM, Katona CLE (eds) Depression and physical illness, vol 6. Wiley & Sons, Chichester

    Google Scholar 

  • Kiefer F (2003) Spezielle pharmakologische Entzugsstrategien. In: Krausz M, Haasen C, Naber D (Hrsg) Pharmakotherapie der Sucht. Karger, Basel, S 14–22

    Google Scholar 

  • Lambert MV, Robertson MM (1999) Depression in epilepsy: etiology, phenomenology and treatment. Epilepsia 40(Suppl 10): 21–47

    Google Scholar 

  • Laux G (2000) Depressive Episode und rezidivierende depressive Störung. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie und Psychotherapie. Springer, Berlin Heidelberg New York Tokio, S 1104–1148

    Google Scholar 

  • Law MR, Thompson SG, Wald NJ (1994) Assessing possible hazards of reducing serum cholesterol. BMJ 308: 373–379

    PubMed  CAS  Google Scholar 

  • Lechleitner M, Hoppichler F, Konwalinka G (1992) Depressive symptoms in hypercholesterolaemic patients treated with pravastatin. Lancet 340: 910

    PubMed  CAS  Google Scholar 

  • Lederberg MS, Holland JC (1995) Psycho-Oncology. In: Kaplan HI, Sadock BJ, Grebb JA (eds) Comprehensive Textbook of Psychiatry/VI. Williams & Wilkins, Baltimore, pp 1570–1592

    Google Scholar 

  • Leppik E (1995) Tiagabine: the safety landscape. Epilepsia 36(Suppl 6): 10–13

    Google Scholar 

  • Lesko LM (1997) Psychologic Issues. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer. Principles & Practice of Oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 2879–2891

    Google Scholar 

  • Levenson J (1993) Cardiovascular disease. In: Stoudemire A, Fogel B (eds) Psychiatric care of the medical patient. Oxford University Press, Oxford

    Google Scholar 

  • Levinson DF, Devinsky O (1999) Psychiatric adverse events during vigabatrin therapy. Neurology 53: 1503–1511

    PubMed  CAS  Google Scholar 

  • Lewis WH (1971) latrogenic psychotic depressive reaction in hypertensive patients. Am J Psychiat 127: 1416–1417

    PubMed  CAS  Google Scholar 

  • Lines C (1994) Hazards of reducing cholesterol. BMJ 309: 541

    PubMed  CAS  Google Scholar 

  • Long T, Kathol R (1993) Critical review of data supporting affective disorder caused by nonpsychotropic medication. Ann Clin Psychiat 5: 259–270

    CAS  Google Scholar 

  • Lyndon RW, Johnson G, McKeough G (1991) Nifedipine induced depression. Br J Psychiatry 36: 447–448

    Google Scholar 

  • Malone D, Dimeff R (1992) Use of fluoxetine in depression associated with anabolic steroid withdrawal: a case report series. Am J Psychiat 53: 130–132

    Google Scholar 

  • McConnell HW, Duffy J, Kress K (1994) Behavioral effects of felbamate. J Neuropsych Clin N 6: 323–326

    Google Scholar 

  • McConnell HW, Duncan D (1998) Behavioral effects of antiepileptic drugs. In: McConnell HW, Snyder PJ (eds) Psychiatric comorbidity in epilepsy. APP, Washington DC, pp 205–244

    Google Scholar 

  • Miyaoka H, Otsubo T, Kamijima K, Ishii M, Onuki M, Mitamura K (1999) Depression from interferon therapy in patients with hepatitis C. Am J Psychiat 156: 1120–1123

    PubMed  CAS  Google Scholar 

  • Modighy K, Robak OH, Vestergaard P (1995) Anticonvulsants in Psychiatry. Wrightson Biomedical, Petersfield

    Google Scholar 

  • Möller HJ, Zerssen D von (1986) Depression in schizophrenia. In: Burrows GD, Norman TR, Rubinstein G (eds) Handbook of studies on schizophrenia, Part I. Elsevier, Amsterdam, pp 183–191

    Google Scholar 

  • Möller HJ, Praag HM van, Aufdembrinke B (1994) Negative symptoms in schizophrenia: considerations for clinical trials. Psychopharmacology 115: 221–228

    PubMed  Google Scholar 

  • Morton S, Lader M (1992) Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects. Pharmacopsychiatry 25: 177–181

    PubMed  CAS  Google Scholar 

  • Mula M, Trimble MR, Lhatoo SD, Sander JWAS (2003) Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia 44(5): 659–663

    Article  PubMed  Google Scholar 

  • Muldoon MF, Barger SD, Ryan CM (2000) Effects of lovastatin on cognitive function and psychosocial well-being. Am J Med 108: 538–547

    Article  PubMed  CAS  Google Scholar 

  • Mulrow LD (1995) Case-finding instruments for depression in primary care settings. Ann Int Med 122:913–921

    PubMed  CAS  Google Scholar 

  • Musselmann DL, Lawson DH, Gumnick JF et al. (2001) Paroxetine for the prevention of depression induced by high-dose interferon alpha. N Engl J Med 344: 961–966

    Google Scholar 

  • Naber D, Sand P, Heigl B (1996) Psychopathological and neuropsychological effects of 8-days’ corticosteroid treatment. Psychoendocrinology 21: 25–31

    CAS  Google Scholar 

  • Neaton JD, Blackburn H, Jacobs D (1992) Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Int Med 152:1490–1500

    CAS  Google Scholar 

  • Ng CH, Schweitzer I (2003) The association between depression and isoretinoin use in acne. Aus NZ J Psychiat 37: 78–84

    Google Scholar 

  • Nickelsen T, Lufkin EG, Riggs BL (1999) Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocinology 24(1): 115–128

    CAS  Google Scholar 

  • Okada F (1985) Depression after treatment with thiazide diuretics for hypertension. Am J Psychiat 142: 1101–1102

    PubMed  CAS  Google Scholar 

  • Olbrich HM, Leucht S, Fritze J, Lanczik MH, Vauth R (2004) Schizophrenien und andere psychotische Störungen. In: Berger M (Hrsg) Psychische Erkrankungen. Klinik und Therapie. Urban & Fischer, München, S 454–540

    Google Scholar 

  • Olden K, Lydiard R (1996) Gastrointestinal disorders. In: Rundell J, Wise M (eds) Consultation-Liaison-Psychiatry. American Psychiatric Press, Washington

    Google Scholar 

  • Patten SB, Love EJ (1993) Can drugs cause depression? A review of the evidence. J Psychiatr Neurosci 18: 92–102

    CAS  Google Scholar 

  • Patten SB, Love EJ (1994) Neuropsychiatric adverse reactions: passive reports to Health and Welfare Canada’s Adverse Reaction Database (1965-present). Int J Psychiat Med 24: 45–62

    CAS  Google Scholar 

  • Patterson JF (1989) Depression associated with enalapril. South Med J 82: 402–403

    PubMed  CAS  Google Scholar 

  • Paykel ES, Flemminger R, Watson JP (1982) Psychiatric side effects of antihypertensive drugs other than reserpine. J Clin Psychopharmacol 2: 14–39

    PubMed  CAS  Google Scholar 

  • Pekkanen J, Nissien A, Punsar S (1989) Serum cholesterol and the risk of accidental or violent death in a 25 year follow-up. The Finnish Cohorts of the Seven Countries Study. Arch Int Med 149: 1589–1591

    CAS  Google Scholar 

  • Pfeiffer HJ, Greenblatt DJ, Koch-Weser J (1976) Clinical use and toxicity of intravenous lidocaine (a report from the Boston Collaborative Drug Surveillance Programm). Am Heart J 92: 168–173

    Google Scholar 

  • Pollak Y, Yirmiya R (2002) Cytokine-induced changes in mood and behaviour: implications for >depression due to a general medical condition<, immunotherapy and antidepressive treatment. Int J Neuropsychoph 5: 389–399

    CAS  Google Scholar 

  • Pope H, Katz D (1988) Affective psychotic symptoms associated with anabolic drug use. Am J Psychiat 145: 487–490

    PubMed  Google Scholar 

  • Prüter C (2003a) Depressive Syndrome bei malignen Erkrankungen. In: Hegerl U, Hoff P (Hrsg) Depressionsbehandlung unter komplizierenden Bedingungen. Komorbidität-Multimedikation — Geriatrische Patienten. Uni-Med, Bremen, S 64–70

    Google Scholar 

  • Prüter C (2003 b) Depressive Syndrome bei Epilepsien. In: Hegerl U, Hoff P (Hrsg) Depressionsbehandlung unter komplizierenden Bedingungen. Komorbidität-Multimedikation — Geriatrische Patienten. Uni-Med, Bremen, S 38–44

    Google Scholar 

  • Prüter C, Norra C (2002) Depressive Störungen und ihre Behandlung bei Epilepsiepatienten. Nervenheilkunde 21: 372–378

    Google Scholar 

  • Prüter C, Norra C (2005) Mood disorders and their treatment in patients with epilepsy. J Neuropsych Clin N 17: 20–28

    Google Scholar 

  • Rauch SL, Stern TA, Zusman RM (1991) Neuropsychiatric considerations in the treatment of hypertension. Int J Psychiat Med 21: 291–308

    CAS  Google Scholar 

  • Ring HA, Reynolds EH (1990) Vigabatrin and behaviour disturbances. Lancet 335:970–971

    Article  PubMed  CAS  Google Scholar 

  • Robertson MM, Katona CLE (1997) Depression and physical illness. Wiley, Chichester

    Google Scholar 

  • Rösche J, Uhlmann C, Möller AA (2004) Psychische Störungen. In: Fröscher W, Vasella F, Hufnagel A (Hrsg) Die Epilepsien. Grundlage-Klinik-Behandlung. Schattauer, Stuttgart, S 243–262

    Google Scholar 

  • Ryback RS, Brodsky L, Munasifi F (1997) Gabapentin in bipolar disorder. J Neuropsychiatry 9:301–305

    CAS  Google Scholar 

  • Sadek A, Fix A, French J (2002) Levetiracetam-related behavioural adverse events: a post marketing study. Epilepsia 43: 151

    Google Scholar 

  • Sadovnick AD, Remick RA, Allen J (1996) Depression and multiple sclerosis. Neurology 46: 628–632

    PubMed  CAS  Google Scholar 

  • Salzberg MR, Vajda FJE (2001) Epilepsy, depression and antidepressant drugs. J Clin Neurosci 8(3): 209–215

    Article  PubMed  CAS  Google Scholar 

  • Schäfer M, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Schmidt F, Grunze H, Lieb K (2002) Interferon alpha (IFN-α) and psychiatric syndromes. A review. Prog Neuro-Psycho 26: 731–746

    Google Scholar 

  • Schäfer M, Schwalger M, Pich M, Lieb K, Heinz A (2003) Neurotransmitter changes by interferon-alpha and therapeutic implications. Pharmacopsychiatry 36(suppl 3): 203–206

    Google Scholar 

  • Scheinmann PL, Peck GL, Rubinow DR, DiGiovanna JJ, Abangan DL, Ravin PD (1990) Acute depression from isoretinoin. J Am Acad Dermatol 22: 1112–1114

    Article  Google Scholar 

  • Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiat 122: 509–522

    PubMed  CAS  Google Scholar 

  • Schleifer S, Slater W, Macari-Hinson M (1991) Digitalis and beta-blocking agents: effects on depression following myocardial infarction. Am Heart J 121: 1397–1402

    Article  PubMed  CAS  Google Scholar 

  • Schmitz B (2002) Effects of antiepileptic drugs on behaviour. In: Trimble MR, Schmitz B (eds) The Neuropsychiatry of Epilepsy. Cambridge University Press, Cambridge, pp 241–255

    Google Scholar 

  • Schwarz R (1995) Psychoonkologie. In: Faust V (Hrsg) Psychiatrie. Ein Lehrbuch für Klinik, Praxis und Beratung. Gustav Fischer, Stuttgart, S 561–568

    Google Scholar 

  • Semenchuk MR, Labiner DM (1997) Gabapentin and lamotrigine: prescribing guidelines for psychiatry. J Prac Psych and Behav Hlth 12: 334–342

    Google Scholar 

  • Smith GD, Shipley MJ, Marmot MG et al. (1994) Plasma cholesterol concentrations and mortality: the Whitehall Study. JAMA 267: 70–76

    Google Scholar 

  • Soares C, Poitras JR, Prouty J (2003) Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs Aging 20(2): 85–100

    PubMed  CAS  Google Scholar 

  • Soyka M, Preuss UW (2000) Körperlicher Entzug. In: Möller HJ (Hrsg) Therapie psychiatrischer Erkrankungen. Thieme, Stuttgart, S 584–604

    Google Scholar 

  • Stewart RA, Sharpies KJ, North FM (2000) Long term assessment of psychological well-being in a randomized placebo-controlled trail of cholesterol reduction with pravastatin. Arch Int Med 160: 3144–3152

    Article  CAS  Google Scholar 

  • Sternbach H, State R (1997) Antibiotics: Neuropsychiatric effects and psychotropic interactions. Harvard Rev Psychiatry 5: 214–226

    CAS  Google Scholar 

  • Strickler R, Stovall DW, Meritt D (2000) Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial. Obstet Gynecol 96(3): 359–365

    Article  PubMed  CAS  Google Scholar 

  • Thiessen B, Wallace S, Blackburn J (1991) Increased prescribing of antidepressant subsequent to beta-blocker therapy. Arch Int Med 150: 2286–2290

    Google Scholar 

  • Tiegs G (1999) Immuntherapeutika. In: Müller-Oerlinghausen B, Lasek R, Düppenbecker H, Munter KH (Hrsg) Handbuch der unerwünschten Arzneimittelwirkungen. Urban & Fischer, München, S 306–316

    Google Scholar 

  • Trimble MR (2000) Anticonvulsants and behaviour: the profile of new drugs with respect to psychosis and depression. Epilepsia 41 (Suppl Florence): 114

    Google Scholar 

  • Vega P, Sweetland A, Acha J, Castillo H, Guerra D, Smith Fawzi MC, Shin S (2004) Psychiatric issues in the management of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 8(6): 749–759

    PubMed  CAS  Google Scholar 

  • Wada K, Yamada N, Sato T, Suzuki H, Miki M, Lee Y, Akiyama K, Kuroda S (2001) Corticosteroid-induced psychotic and mood disorders. Psychosomatics 42(6): 461–466

    Article  PubMed  CAS  Google Scholar 

  • Wardle J, Rogers P, Judd P (2000) Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological functioning. Am J Med 108: 547–553

    Article  PubMed  CAS  Google Scholar 

  • Wysowski DK, Pitts M, Beitz J (2001) Depression and suicide in patients treated with isoretinoin. N Engl J Med 344: 460–466

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gangelter Einrichtungen, Krankenhaus Maria Hilf, Fachkrankenhaus für Psychiatrie und Psychotherapie, Bruchstr. 6, 52538, Gangelt

    Dr. med. C. Prüter

Authors
  1. Dr. med. C. Prüter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik, Helios-Kliniken Schwerin, Wismarsche Straße 392-397, 19049, Schwerin

    Frank Block

  2. Gangelter Einrichtungen Krankenhaus Maria Hilf, Fachkrankenhaus für Psychiatrie und Psychotherapie, Brunchstraße 6, 52538, Gangelt

    Christian Prüter

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Prüter, C. (2006). Depression. In: Block, F., Prüter, C. (eds) Medikamentös induzierte neurologische und psychiatrische Störungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28604-7_23

Download citation

  • DOI: https://doi.org/10.1007/3-540-28604-7_23

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28590-8

  • Online ISBN: 978-3-540-28604-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation